NASDAQ$ALHC

Alignment Healthcare Inc · Q3 2021 earnings

Q3 2021 earnings · · Investor relations

Briefing

Reported a strong quarter of performance across all key metrics, focusing on continuous improvement and leveraging the AVA technology platform.

Alignment Healthcare reported strong financial results for the third quarter ended September 30, 2021, driven by a focus on continuous improvement and leveraging their AVA technology platform.

  • Reported financial results for the third quarter ended September 30, 2021.
  • Focused efforts on continuous improvement to deliver high-quality care.
  • Leveraged the power of the AVA technology platform, care model, and provider engagement efforts.
  • Enhanced product offerings, reflecting a commitment to putting seniors first.

Headline financials

Total Revenue

$293M

Previous: $248M+18.4%
EPS (adj)

-$0.26

Previous: $0.07-464.7%
Free Cash Flow

-$45.8M

No prior period
Net Income

-$45.8M

Previous: $10.8M-522.4%
Operating Income

-$41.5M

Previous: $15.1M-375.2%
Gross Profit

$293M

Previous: $57.8M+407.8%
Cash & Equivalents

$500M

No prior period
Total Assets

$657M

No prior period

Revenue & EPS history

Alignment Healthcare · Revenue · Quarterly

$293M

Q3 2021+18.4%vs Q3 2020
Beat estimate in 12 of 12 quarters(100%)
ActualEstimate

Revenue by segment

Alignment Healthcare · $265M total across 2 segments · Q1 2021

  • Earned premiums
    $265M+18.0%
  • Other revenue
    $82K

Forward guidance

The release contains forward-looking statements regarding future growth and the financial outlook for the fourth quarter ended December 31, 2021 and year ended December 31, 2021.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2021

Historical avgQ3 2021

+1.8%

Avg return

Earnings day

+1.8%

Avg return

5 days after

+2.6%

Avg return

30 days after

57%

12 / 21 earnings

Positive

+27.0%

Q1 2024

Best reaction

-16.4%

Q4 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+3.8%-15.7%-29.5%
Q4 2025-5.8%-7.5%-18.6%
Q3 2025-1.9%-0.4%+12.2%
Q1 2025-7.7%-7.5%-8.3%
Q4 2024+16.5%+17.4%+35.9%
Q3 2024+1.6%+12.2%+11.2%
Q2 2024+2.3%+4.9%+3.1%
Q1 2024+27.0%+31.6%+51.0%
Q4 2023-8.9%-9.2%-20.1%
Q3 2023-9.6%-7.2%+10.5%
Q2 2023+7.5%+10.5%-4.2%
Q1 2023+3.5%+11.3%-5.1%
Q4 2022-16.4%-20.9%-35.2%
Q3 2022-3.1%-3.3%-2.7%
Q2 2022+10.4%+4.3%-8.7%
Q1 2022-7.0%-18.8%+6.8%
Q4 2021+10.7%+8.0%+39.7%
Q3 2021+10.6%+6.1%-26.7%
Q2 2021-8.5%-4.8%-11.2%
Q1 2021+6.8%+13.3%+27.6%
Q4 2020+6.8%+13.3%+27.6%
Q3 2020
Q2 2020
Q1 2020

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro